Nine states have been pursuing the idea of prescription drug affordability boards. Maryland's board just set limits on the ...

The Trump administration is opening the floodgates for Affordable Care Act exchanges to feature plans that offer bare-bones ...

China's ascent is forcing U.S. biotech companies and investors to pick a side: Is it an ally or an existential threat?

The White House announced an expansion of its prescription drug discount platform, TrumpRx, on Monday, adding more than 600 ...

Today we’re bringing you a special report: a fascinating look at how China’s growing role in global drug development is ...

With no approved vaccine for the fast-growing Ebola outbreak in the DRC, experts weigh testing one with unknown protection.

In response to an Ebola outbreak, the U.S. has banned entry for noncitizens who have been in the Democratic Republic of the ...

The Supreme Court on Monday dealt a major blow to the brand drug industry’s legal campaign against the Medicare drug price ...

Texas Attorney General Ken Paxton secured a settlement with Texas Children’s Hospital that compels the hospital to create the ...

Opinion: Vaccine policy it is not a matter of autonomy at all, because infants do not decline vaccination — their parents do.

Jesse Goodman, former director of CBER and former FDA chief scientist, calls for five critical changes to restore trust in ...